Is female gender associated with a worse prognosis in patients with Hypertrophic Cardiomyopathy?
Female gender is associated with a worse prognosis in hypertrophic cardiomyopathy, highlighting the potential need for earlier identification and more aggressive, gender-based management strategies in women.
Female gender was associated with a worse prognosis in HCM. These findings suggest the need for improved care in women including early identification of disease and more possible aggressive management. Moreover, gender-based strategy may benefit in HCM patients.
Trongtorsak et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: